© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel
December 23, 2020
Brenna L. Brady, PhD , Matthew Lucci, MPH , Kathleen Wilson, MPH , Kathleen M. Fox, PhD , Jeffrey Wojtynek, PharmD , Chelsea Cooper, PharmD , Helen Varker, BS , Christina Larson Chebili, MA , Igoni Dokubo, MD
Evidence-Based Oncology, January 2021, Volume 27, Issue 1
Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.